Opera OVID

Ovid Therapeutics Inc

-

00:00:00

Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment of seizures associated with tuberous sclerosis complex and infantile spasms; and OV350, a small molecule for treating epilepsies. It also develops OV882, a short hairpin RNA gene therapy for the treatment of angelman syndrome; and OV815 for the treatment of kinesin-family of proteins associated neurological disorder. The company has license and collaboration agreements with Healx, AstraZeneca AB, H. Lundbeck A/S, and Northwestern University, as well as Marinus Pharmaceuticals, Inc. The company was incorporated in 2014 and is headquartered in New York, New York.
Seguir leyendo

OVID
Especificaciones comerciales

Dígitos

3

Punto

0.001

Spread

floating

Tamaño del contrato

1

Volumen Min

1

Volumen máximo

10,000

Volumen Paso

1

Intercambio Largo (Puntos)

-0.460

Swap Corto (Puntos)

-0.270
Disponible en
MT5, TV, cTrader
Última actualización a las junio 17, 19:07 GMT+3
*Fuente de datos: MT5 Server Prime Account Pricing

OVID
Calendario económico

No se han encontrado datos

1D Cambio

206.604%

¿Por qué BlackBull Markets?

26k+

Activos Disponibles

1:500

Apalancamiento de hasta

Regulado

Multirregulado

24/7

Atención al Cliente

$0

Sin Depósito Mínimo

Calculadora de márgenes

Resultados de Cálculo

Precio Actual

0.85

Margen Requerido

Moneda Convertida

Margen Requerido

Moneda Base de la Cuenta

Calculadora de pérdidas y ganancias

Resultados de Cálculo

Valor del PIP:

Pérdida de parada en PIPs

Pérdida de parada en :

Tomar ganancia en PIPs

Tomar ganancia en :

Calculadora de swaps

Resultados de Cálculo

0.85

Join Now